Burton Sensors, Inc. Custom Case Solution & Analysis

Evidence Brief: Burton Sensors, Inc.

1. Financial Metrics

Metric	Value / Detail	Source
Burton Revenue (2016)	9.8 million dollars	Exhibit 1
Burton Net Income (2016)	418,000 dollars	Exhibit 1
ESI Acquisition Price	1.5 million dollars (asking price)	Paragraph 14
Burton Cash Balance	122,000 dollars	Exhibit 2
Current Ratio Requirement	Minimum 2.0 (Bank Covenant)	Paragraph 22
Line of Credit Limit	2.0 million dollars	Paragraph 21
ESI Revenue (2016)	1.1 million dollars	Paragraph 15

2. Operational Facts

Product Focus: Burton specializes in temperature and pressure sensors for industrial and aerospace applications.
Technology Gap: Burton lacks thermistor technology, which is the primary growth driver in the medical device sector.
ESI Capability: Electro-Sensors (ESI) holds proprietary manufacturing processes for high-precision thermistors.
Internal Development: Marshall Burton estimates that developing thermistor technology internally would take three years and cost approximately 600,000 dollars in R and D.
Production Capacity: Burton operates a 45,000 square foot facility currently at 70 percent capacity.

3. Stakeholder Positions

Marshall Burton (CEO): Advocates for the acquisition to accelerate entry into the medical market and modernize the product portfolio.
Richard Burton (Founder/Chairman): Concerned about debt levels and the erosion of family ownership; prefers organic, slower growth.
City National Bank (Lender): Maintains strict covenants regarding the current ratio and debt-to-equity; unlikely to expand credit without equity injection.
Sarah Burton (VP Marketing): Identifies a 15 percent annual growth potential in the medical sensor segment if the ESI technology is acquired.

4. Information Gaps

ESI Balance Sheet: The case does not provide a full list of ESI liabilities or existing debt.
Integration Costs: The specific costs to move ESI machinery to the Burton facility are not quantified.
Customer Concentration: The percentage of ESI revenue tied to its top three customers is unknown.

Strategic Analysis

1. Core Strategic Question

How can Burton Sensors bridge its technological gap in the high-growth medical thermistor market while remaining within the restrictive financial covenants set by its primary lender?
Should the company prioritize speed to market via the ESI acquisition or preserve capital through internal development?

2. Structural Analysis

Applying the Build-Buy-Borrow framework reveals a clear imperative for acquisition. The medical sensor market is evolving rapidly. A three-year internal development cycle would leave Burton two generations behind competitors. The Value Chain analysis indicates that ESI brings a specialized manufacturing capability that Burton cannot easily replicate. However, the bargaining power of the bank is the primary structural constraint. Burton is currently near its debt ceiling, and the 1.5 million dollar price tag represents nearly four times the current annual net income.

3. Strategic Options

Option 1: Acquire ESI via Debt and Equity Mix. Raise 750,000 dollars from family members or private investors and finance the remaining 750,000 dollars through the existing line of credit. This maintains the bank covenants and secures the technology immediately.
Option 2: Internal R and D (Organic Growth). Invest 200,000 dollars annually for three years. This preserves ownership but risks total obsolescence in the medical segment.
Option 3: Strategic Partnership/Licensing. License the thermistor technology from ESI for a royalty fee. This minimizes upfront capital but fails to secure the proprietary manufacturing process as a long-term asset.

4. Preliminary Recommendation

Burton should pursue Option 1. The 15 percent growth rate in the medical segment is the only viable path to increasing the enterprise value of the firm. Internal development is too slow, and licensing does not provide the competitive moat required. The acquisition must be contingent on an equity injection to prevent a covenant breach that would trigger a liquidity crisis.

Implementation Roadmap

1. Critical Path

Phase 1 (Days 1-30): Secure 750,000 dollars in equity commitments from the Burton family or external private placement. This is the prerequisite for bank approval.
Phase 2 (Days 31-45): Finalize due diligence on ESI with a focus on intellectual property validity and customer contracts.
Phase 3 (Days 46-60): Execute the purchase agreement and initiate the physical relocation of ESI equipment to the Burton facility.
Phase 4 (Days 61-90): Consolidate the sales force and launch the combined product catalog to medical device manufacturers.

2. Key Constraints

Bank Covenants: The 2.0 current ratio is non-negotiable. Any plan that relies 100 percent on the line of credit will fail.
Management Bandwidth: Marshall Burton is currently handling both strategy and operations; the integration of ESI will require a dedicated project lead to avoid core business slippage.

3. Risk-Adjusted Implementation Strategy

The plan assumes a 20 percent contingency for integration costs. If the equity raise falls short, the company must negotiate a staged buyout of ESI—paying 1.0 million dollars upfront and 500,000 dollars as an earn-out based on future sales. This reduces the immediate cash outflow and aligns the interests of the ESI founders with Burton's success.

Executive Review and BLUF

1. BLUF (Bottom Line Up Front)

Burton Sensors must acquire Electro-Sensors (ESI) for 1.5 million dollars using a mix of equity and debt. Organic development is rejected as the three-year timeline is incompatible with market growth rates. The acquisition provides immediate access to the medical thermistor segment, which is projected to grow at 15 percent annually. To avoid breaching bank covenants, the firm must raise at least 700,000 dollars in equity. Failure to act now will result in the permanent loss of the medical market to better-capitalized competitors.

2. Dangerous Assumption

The analysis assumes that ESI's manufacturing process is easily transferable to the Burton facility without significant yield loss. If the precision of the thermistor production relies on the specific environment or staff at ESI that do not transition, the 1.5 million dollar investment will be a total loss.

3. Unaddressed Risks

Liquidity Risk: Even with an equity mix, the combined entity will have minimal cash reserves for the first 12 months. Any downturn in the industrial sensor market will cause a default.
Integration Friction: The culture of a small, founder-led firm like ESI may clash with the more established Burton hierarchy, leading to the departure of key technical talent post-acquisition.

4. Unconsidered Alternative

The team did not evaluate a joint venture where Burton and ESI create a third entity specifically for medical sensors. This would allow Burton to access the technology without the full 1.5 million dollar capital outlay and would keep the debt off the Burton balance sheet, protecting the current ratio.